VA North Texas Health Care System, The University of Texas Southwestern Medical School, Dallas, TX, USA.
University of Patras, Patras, Greece.
Int J Cardiol. 2014 Jun 15;174(2):243-8. doi: 10.1016/j.ijcard.2014.04.004. Epub 2014 Apr 12.
The efficacy and safety profile of retrograde chronic total occlusion (CTO) percutaneous coronary intervention (PCI) has received limited study. We sought to perform a weighted meta-analysis of the success and complication rates of retrograde CTO PCI.
We conducted a meta-analysis of 26 studies published between 2006 and April 2013 reporting in-hospital outcomes of retrograde CTO PCI. Data on procedural success, frequency of death, emergent coronary artery bypass graft surgery (CABG), stroke, myocardial infarction (MI), perforation, tamponade, stent thrombosis, major vascular or bleeding events, contrast nephropathy, and radiation skin injury were collected.
A total of 26 studies with 3482 patients and 3493 target CTO lesions were included. Primary retrograde CTO PCI was attempted in 52.4%. Pooled estimates of outcomes were as follows: procedural success 83.3% [95% confidence interval (CI): 79.0% to 87.7%]; death 0.7% (95% CI: 0.5% to 1.2%); urgent CABG 0.7% (95% CI: 0.4% to 1.2%); tamponade 1.4% (95% CI: 1.0% to 2.2%); collateral perforation 6.9% (95% CI: 4.6% to 10.4%); coronary perforation 4.3% (95% CI: 1.2% to 15.4%); donor vessel dissection 2% (95% CI: 0.9% to 4.5%); stroke 0.5% (95% CI: 0.2% to 1.0%); MI 3.1% (95% CI: 0.2% to 5.0%); Q wave MI 0.6% (95% CI: 0.4% to 1.1%); vascular access complications 2% (95% CI: 0.9% to 4.5%); contrast nephropathy 1.8% (95% CI: 0.8% to 3.7%); and wire fracture and equipment entrapment 1.2% (95% CI: 0.6% to 2.5%).
Retrograde CTO PCI is associated with high procedural success rate and acceptable risk for procedural complications.
逆行慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)的疗效和安全性已得到有限研究。我们试图对逆行 CTO PCI 的成功率和并发症发生率进行加权荟萃分析。
我们对 2006 年至 2013 年 4 月期间发表的 26 项研究进行了荟萃分析,这些研究报告了逆行 CTO PCI 的住院期间结果。收集了手术成功率、死亡率、紧急冠状动脉旁路移植术(CABG)、卒中和心肌梗死(MI)、穿孔、心脏压塞、支架血栓形成、主要血管或出血事件、造影剂肾病和辐射皮肤损伤的数据。
共有 26 项研究纳入了 3482 例患者和 3493 例靶 CTO 病变。初次尝试逆行 CTO PCI 的占 52.4%。结果的汇总估计值如下:手术成功率 83.3%(95%可信区间[CI]:79.0%至 87.7%);死亡率 0.7%(95% CI:0.5%至 1.2%);紧急 CABG 0.7%(95% CI:0.4%至 1.2%);心脏压塞 1.4%(95% CI:1.0%至 2.2%);侧支穿孔 6.9%(95% CI:4.6%至 10.4%);冠状动脉穿孔 4.3%(95% CI:1.2%至 15.4%);供体血管夹层 2%(95% CI:0.9%至 4.5%);卒中 0.5%(95% CI:0.2%至 1.0%);心肌梗死 3.1%(95% CI:0.2%至 5.0%);Q 波心肌梗死 0.6%(95% CI:0.4%至 1.1%);血管入路并发症 2%(95% CI:0.9%至 4.5%);造影剂肾病 1.8%(95% CI:0.8%至 3.7%);和导丝断裂和设备嵌顿 1.2%(95% CI:0.6%至 2.5%)。
逆行 CTO PCI 与高手术成功率和可接受的手术并发症风险相关。